Tate & Lyle's £2.7bn takeover by US rival Ingredion marks a major milestone in the company's 123-year history, with the American firm valuing the UK business at 615p per share – a premium that has convinced Tate & Lyle's board to endorse the proposal.
The deal represents a significant shift in ownership for a company that was once a stalwart of the London Stock Exchange. According to industry analysts, Ingredion's £2.7bn offer is equivalent to approximately 20% above Tate & Lyle's closing share price in the days leading up to the announcement.
This acquisition is the latest example of a prominent UK-listed company being bought out by a foreign entity, fuelling broader questions about the competitiveness of the London Stock Exchange and the valuation of British businesses on the global stage. Over the past year alone, several high-profile UK companies have changed hands – including Reckitt Benckiser's £13bn sale to US-based Reckitt.
Tate & Lyle's rich history spans over a century, evolving from its origins in sugar refining to become a global leader in specialist food ingredients. Its products are widely used across the food and beverage industry, contributing to the taste, texture, and nutritional profiles of numerous consumer goods – with some 40% of sales coming from North America.
Ingredion, a well-established player in the food ingredients sector, is set to integrate Tate & Lyle's operations, aiming to strengthen its global presence and product portfolio. Industry experts suggest that the strategic rationale behind the acquisition involves enhancing market share, expanding into new geographical regions, and leveraging combined research and development capabilities.
The takeover will undoubtedly bring changes for Tate & Lyle's employees and stakeholders, though the full implications are yet to be detailed. Regulatory approvals remain a critical step in the deal's progression, with investors eager to see how Ingredion plans to integrate the UK business into its operations.